EBMT 2021 | Go-CAR-T: harnessing data on CAR-T therapy
Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, gives an overview of the GO-CAR-T initiative which is promoting the use of data from patients who have received chimeric antigen receptor T-cell (CAR-T) therapy at EU or EBMT affiliated programs. The aim of the Go-CAR-T initiative is to collect high-value data to design clinical trials, to improve access to data and to measure the medical value of CAR-T therapy. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.
Disclosures
Prof. Christian Chabannon, MD, PhD, has participated in consultancy work or speakers bureaus for Kite/Gilead, Novartis, BMS/Celgene, Janssen, Bellicum Pharmaceuticals, BlueBirdBio, Sanofi SA and Terumo BCT.
